Pilot Study of Elemene in Treating Patients With Refractory Glioblastoma

NCT04674527 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Refractory Glioblastoma

Interventions

DRUG: Elemene
DRUG: Temozolomide

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]